Commerzbank Aktiengesellschaft’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-11,000
Closed -$284K 1250
2015
Q3
$284K Buy
+11,000
New +$284K ﹤0.01% 971
2015
Q2
Sell
-21,000
Closed -$529K 1252
2015
Q1
$529K Buy
21,000
+1,000
+5% +$25.2K ﹤0.01% 936
2014
Q4
$469K Sell
20,000
-15,000
-43% -$352K ﹤0.01% 1015
2014
Q3
$797K Buy
35,000
+21,200
+154% +$483K ﹤0.01% 878
2014
Q2
$337K Buy
+13,800
New +$337K ﹤0.01% 1070
2014
Q1
Sell
-42,800
Closed -$947K 1490
2013
Q4
$947K Sell
42,800
-3,300
-7% -$73K ﹤0.01% 905
2013
Q3
$987K Buy
46,100
+5,300
+13% +$113K ﹤0.01% 865
2013
Q2
$812K Buy
+40,800
New +$812K ﹤0.01% 960

Other funds holding QGENF

Commerzbank Aktiengesellschaft's QGENF Position: Q1 2017 in Review

Commerzbank Aktiengesellschaft sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 331,022 shares — an estimated $9.28M sold.

Commerzbank Aktiengesellschaft first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $31.3M in Q4 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Commerzbank Aktiengesellschaft reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 331,022 QIAGEN NV shares in Q1 2017, an estimated $9.28M.
  • Commerzbank Aktiengesellschaft first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Commerzbank Aktiengesellschaft's QIAGEN NV position peaked at $31.3M in Q4 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.